Complete Remission in Advanced Epithelial Ovarian Cancer is Predicted by Metabolic Signatures Measured in the Media of Patient's Primary Culture 3D Tumor Explants LONG BEACH, Calif., April 11, 2022 /PRNewswire/ -- Investigators at the Nagourney Cancer Institute and Metabolomycs, Inc. will...